EDCTP-TDR Clinical Research and Development Fellowships


 

Deadline: 28 February 2020

Describtion

Researchers from low- and middle-income countries (LMICs) who are involved in clinical research activities have limited opportunities to acquire experience and develop skills for conducting clinical trials outside an academic or public sector setting. As a result, there are few researchers and clinical staff from LMICs assuming leading roles in clinical research for poverty-related diseases (PRDs). The development of human capacities through fellowships will lead to enhanced and sustainable research capacity in LMICs on diagnostics, drugs and vaccines for PRDs by supporting career progression and retention of researchers in LMICs.

As part of the EDCTP Association’s capacity building efforts, the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the EDCTP Association signed a Memorandum of Understanding (MoU) in January 2013 to implement a fellowship scheme that offers placements in European-based companies to individual researchers and clinical staff from sub-Saharan Africa working in the implementation of clinical trials.

The TDR Career Development Fellowships (CDF) programme, which has been supported by the Bill & Melinda Gates Foundation and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), offers targeted training in research and development to skill local personnel in disease-endemic LMICs with competencies in clinical trials for drugs, vaccines and diagnostics on a broad range of infectious diseases of poverty. The CDF programme is implemented by the Special Programme for Research and Training in Tropical Diseases (TDR). TDR is hosted at the World Health Organization (WHO) and is sponsored by the United Nations Children’s Fund (UNICEF), the United Nations Development Programme (UNDP), the World Bank and WHO.

The EDCTP Association and TDR decided to implement this fellowship scheme through a joint call for proposals. This joint call will have a leverage effect on the number of individuals trained, resulting in an increased impact on research and development capacity in LMICs. The partnership will ensure synergies between the different parties involved and will facilitate communication with researchers and clinical staff, academic affiliated research institutions, clinical research organisations (CROs), pharmaceutical companies and product development partnerships (PDPs).

This call will have an incremental effect on the number of individuals trained, resulting in an increased impact on research and development capacity in LMICs. The partnership will ensure synergies and facilitate communication between the different parties involved.

Scope

The purpose of the TDR CRDF is to provide funding support to researchers and clinical trial staff from LMICs to acquire essential skills in clinical research and development through placements in host training organizations. The scheme targets early to mid-career researchers or clinical trial staff who are employed by a legal entity in LMICs where they are currently conducting clinical research activities in the scope of TDR.

TDR will fund fellows employed by academic and/or research institutions in any LMIC to be placed in host training organizations, either in or outside Europe, to train and develop new research skills on poverty related infectious diseases, including HIV/AIDS, TB, malaria, Ebola and NTDs.

Fellows can only be funded once under this grant scheme. Grants awarded are not transferrable from one individual to another. Placements at host training organizations are for a period of 12 months followed by a reintegration period of 12 months in their home institution. Fellows must be committed to return to their home institution for a minimum of two years after completion of the two-year fellowship. Fellows should be able to demonstrate how the experience gained during the training programme will be applied upon return to their home organization.

Eligibilities

A proposal/application will only be considered eligible if:

  1. its content corresponds, wholly or in part, to the topic/contest description for which it is submitted;
  2. it complies with the eligibility conditions for participation set out below, depending on the type of action:
    • The applicant must be a legal entity established in sub-Saharan Africa and must be the home organisation employing the fellow5.
    • The applying fellow must:
      • be a post-graduate (MSc or PhD) or medical graduate with clinical and/or research experience in infectious diseases;
      • have obtained their post-graduate or medical graduate degree within 15 years of submission of the application;
      • be a researcher or clinical staff member employed for the last 12 months in an organisation with a registered legal entity in sub-Saharan Africa, and who has been conducting clinical research activities in the scope of the EDCTP2 programme;
      • provide a letter of support from the home organisation for the fellowship which is justifying the training needs of the fellow and explaining how the home organisation will benefit from the fellowship and how the reintegration of the fellow will be ensured6;
      • not have been funded under this fellowship scheme before7.
    • The requested EDCTP2 programme contribution per action shall not exceed EUR 100,000;
    • Placements sought shall be for a period of 15 months, following which there will be a re-integration period of up to 6 months.

For TDR:

  • The applying fellow must:
    • be national or citizen and resident in an LMIC;
    • be a post-graduate (MSc or PhD) or medical graduate with clinical and/or research experience in infectious diseases;
    • have obtained their post-graduate;
    • be a researcher or clinical staff member employed for the last 12 months in an organisation with a registered legal entity in an LMIC conducting clinical research activities in the scope of the TDR programme;
    • provide a letter of support from the home organisation for the fellowship which is justifying the training needs of the fellow and explaining how the home organisation will benefit from the fellowship and how the reintegration of the fellow will be ensured;
    • not have been funded under this fellowship scheme before.

Call for applications in PDF format pdf, 185kb

For more information and application: WEBSITE